Genetic testing identifies the chance of a person to develop or pass on a genetic disorder.

Cancer testing, the leading application of the Global Genetic Testing Market

Over 2,000 genetic tests are currently in practice and more are under the process of development”

The continuous evolution of medical sciences have found answers for many unsolved riddles and is expanding to reach various unmet conditions. One such solution is the development of genetic testing, which involves the identification of changes in human DNA to trace the presence of chronic genetic disorders. Over 2,000 genetic tests are currently in practice, and more are under the process of development.

The Global Genetic Testing Market was valued around USD 49.26 million in 2018 and is anticipated to grow at a CAGR of 9.51% to reach USD 77.58 Million by 2023.

Genetic testing is carried out for different reasons like pre-implantation genetic diagnosis, prenatal testing, carrier testing, predictive genetic testing, diagnostic genetic testing, pharmacogenetic testing, and others. These types of genetic testing do not involve any special counselor or consultant unless the choice of the consumer.

Sample Report: https://www.marketdataforecast.com/market-reports/global-genetic-testing-market-36/request-sample

Several diseases like haemophilia, cystic fibrosis, sickle cell anaemia, and other diseases can be diagnosed in the early stages with the aid of genetic testing. Increasing proportion of the aging population and raising awareness about the potential benefits of genetic testing are the principal reasons for expanding the scope of the genetic testing market. Additionally, new developments in the diagnosis, increasing healthcare expenses of the people, and the growing number of cancer patients are also supplementing the market boom.

On the contrary, the expenses associated with the testing along with the lack of proper standards to confirm the accuracy are some of the hindering factors for the market expansion.

Find out more from: https://www.marketdataforecast.com/market-reports/global-genetic-testing-market-36/

The complete report for the global genetic testing market provides all the information required for the decision making and investing opportunities based on the market size, revenue, history, current trends and future predictions. It also provides the deep sights of the global market based on the type, application, and regional analysis, along with the competitive landscape.

Based on the type, the market is segmented into carrier testing, diagnostic testing, prenatal testing and neonatal testing. Prenatal testing that screens the new-borns for possible future diseases is expected to expand hugely in the forecast period till 2021. Diagnostic testing that determines whether a patient is a carrier is also projected to have a large growth rate.

Based on the application, the market is segmented into cancer testing, pharmacogenomics testing, prenatal testing, and predisposition testing. Of these, the cancer testing segment is estimated to lead the global genetic testing market in the forecast period. The market for screening the new-borns and calculating the probability of occurrence of diseases is expected to expand more.

Based on the regional analysis, the market is studied in North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. North America is expected to contribute the largest share to the market in the coming years. In the whole world, the US possesses the largest market for genetic testing. The increasing awareness about the prevalence of genetic diseases, high awareness about the process and favorable government reimbursements are expected to contribute a lot to the growth of the market.

Customized Report: https://www.marketdataforecast.com/market-reports/global-genetic-testing-market-36/customize-report

The report also provides information about some of the leading players in the world genetic testing market. Some of them are Abbott Laboratories, Roche Molecular Diagnostics Inc., Abbott Molecular Inc., AutoGenomics Inc., Celera Group, ELITech Group, BioRad Laboratories, PerkinElmer Inc., Roche Diagnostics Corp., Quest Diagnostics Inc., Transgenomic Inc., and Applied Biosystems Inc.

The future holds promise for the genetic testing market with the increasing cases of genetic disorders among the world population. Improving standards in patient care coupled with the advances in the technology are expected to create ample opportunities for the growth of the market in the following years. Existing players in the market are investing heavily in the research and development activities to increase the products and services used for genetic testing. This aggressive involvement from key players is anticipated to stimulate the rapid expansion of the global genetic testing market in the future.

Scope of the report:
• Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
• A segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies

About Us:
Market Data Forecast is a firm working in market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for most of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest.

Contact info:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com

This release was published on openPR.